Recent studies have also shown that Sema3A increase in ALS is not limited to the periphery [39], but it is also a central phenomenon affecting motor neurons in the motor cortex of sporadic ALS patients [33], astrocytes in cases of spinal cord injury [40] and oligodendrocytes in multiple sclerosis [41]. This evidence concerns the gene SEMA3A and multiple sclerosis.